Complete pathologic response of HER2-positive breast cancer liver metastasis with dual Anti-HER2 antagonism

被引：0
|
作者：
Hans F Schoellhammer
Felicia Hsu
Courtney Vito
Peiguo Chu
Jinha Park
James Waisman
Joseph Kim
机构：
[1] City of Hope Comprehensive Cancer Center,Division of Surgical Oncology, Department of Surgery
[2] City of Hope Comprehensive Cancer Center,Department of Pathology
[3] City of Hope Comprehensive Cancer Center,Department of Radiology
[4] City of Hope Comprehensive Cancer Center,Department of Medical Oncology and Experimental Therapeutics Research
来源：
BMC Cancer | / 14卷
关键词：
HER2-positive breast cancer; Targeted therapy; Breast cancer liver metastases; Trastuzumab; Pertuzumab; Complete pathologic response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Response to anti-HER2 neoadjuvant chemotherapy in HER2-positive invasive breast cancers with different HER2 FISH patterns
    Lv, Hong
    Bai, Qian-Ming
    Li, Ming
    Cai, Meng-Yuan
    Zhou, Shu-Ling
    Liu, Yin
    Wang, Zhong-Hua
    Shui, Ruo-Hong
    Lu, Hong-Fen
    Xu, Xiao-Li
    Yu, Bao-Hua
    Tu, Xiao-Yu
    Bi, Rui
    Cheng, Yu-Fan
    Zhou, Xiao-Yan
    Shao, Zhi-Min
    Yang, Wen-Tao
    JOURNAL OF CLINICAL PATHOLOGY, 2024,
  • [22] HER2 Intratumoral Heterogeneity Is Associated with Incomplete Response to Anti-HER2 Neoadjuvant Chemotherapy in HER2-Positive Breast Carcinoma
    Li, Zaibo
    Nitta, Hiroaki
    Hou, Yanjun
    Banks, Peter
    MODERN PATHOLOGY, 2017, 30 : 55A - 55A
  • [23] Role of plasma circulating HER2/EFTUD2 ratio in predicting pathological complete response (pCR) after neoadjuvant dual anti-HER2 therapy in HER2-positive breast cancer (HER2+BC).
    Chan, Jeffrey C. H.
    Cho, William C. S.
    Chow, James C. H.
    Bao, Kelvin K. H.
    Leung, Alex K. C.
    Szeto, Michelle O. Y.
    Ho, Connie H. M.
    Yiu, Harry H. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] The perspective of anti-HER2 therapy for HER2 positive breast cancer
    Iwata, Hiroji
    ANNALS OF ONCOLOGY, 2015, 26 : 11 - 11
  • [25] Pathologic Complete Response in HER2-Positive Breast Cancers with Radiographically Extensive Disease
    Pak, L. M.
    Chikarmane, S. A.
    Barrios, M.
    Schnitt, S. J.
    King, T. A.
    Mittendorf, E. A.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S148 - S148
  • [26] Margetuximab Anti-HER2 monoclonal antibody Treatment of metastatic HER2-positive breast cancer Treatment of HER2-positive gastric or gastroeso-phageal junction cancer
    Hanna, K. S.
    DRUGS OF THE FUTURE, 2021, 46 (03) : 191 - 195
  • [27] Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival
    Yap, Y. S.
    Cornelio, G. H.
    Devi, B. C. R.
    Khorprasert, C.
    Kim, S. B.
    Kim, T. Y.
    Lee, S. C.
    Park, Y. H.
    Sohn, J. H.
    Sutandyo, N.
    Wong, D. W. Y.
    Kobayashi, M.
    Landis, S. H.
    Yeoh, E. M.
    Moon, H.
    Ro, J.
    BRITISH JOURNAL OF CANCER, 2012, 107 (07) : 1075 - 1082
  • [28] Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival
    Y S Yap
    G H Cornelio
    B C R Devi
    C Khorprasert
    S B Kim
    T Y Kim
    S C Lee
    Y H Park
    J H Sohn
    N Sutandyo
    D W Y Wong
    M Kobayashi
    S H Landis
    E M Yeoh
    H Moon
    J Ro
    British Journal of Cancer, 2012, 107 : 1075 - 1082
  • [29] First FDA Approval of Dual Anti-HER2 Regimen: Pertuzumab in Combination with Trastuzumab and Docetaxel for HER2-Positive Metastatic Breast Cancer
    Blumenthal, Gideon M.
    Scher, Nancy S.
    Cortazar, Patricia
    Chattopadhyay, Somesh
    Tang, Shenghui
    Song, Pengfei
    Liu, Qi
    Ringgold, Kimberly
    Pilaro, Anne M.
    Tilley, Amy
    King, Kathryn E.
    Graham, Laurie
    Rellahan, Barbara L.
    Weinberg, Wendy C.
    Chi, Bo
    Thomas, Colleen
    Hughes, Patricia
    Ibrahim, Amna
    Justice, Robert
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2013, 19 (18) : 4911 - 4916
  • [30] Pathologic Complete Response in HER2-Positive Breast Cancer Patients Receiving Trastuzumab in Neoadjuvant Setting
    Sheikh, Fareeha
    Nazir, Adil
    Yasmeen, Samia
    Badar, Farhana
    Ahmad, Usman
    Siddiqui, Neelam
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2019, 29 (02): : 159 - 163
12345